Platinum Group Metals Limited (USA) (PLG) formed multiple bottom with $1.51 target or 4.00% below today’s $1.57 share price. Platinum Group Metals Limited (USA) (PLG) has $209.11M valuation. The stock decreased 7.65% or $0.13 during the last trading session, reaching $1.57. About shares traded. Platinum Group Metals Limited (USA) (NYSEMKT:PLG) has declined 46.60% since August 29, 2016 and is downtrending. It has underperformed by 54.84% the S&P500.
Among 2 analysts covering Neovasc (NASDAQ:NVCN), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Neovasc had 6 analyst reports since August 12, 2015 according to SRatingsIntel. Ladenburg Thalmann downgraded the stock to “Neutral” rating in Friday, May 20 report. The company was maintained on Tuesday, August 25 by Canaccord Genuity. Zacks downgraded Neovasc Inc (US) (NASDAQ:NVCN) on Wednesday, August 26 to “Hold” rating. The stock of Neovasc Inc (US) (NASDAQ:NVCN) has “Buy” rating given on Thursday, December 10 by Ladenburg Thalmann. The rating was downgraded by Zacks on Wednesday, August 12 to “Buy”. The rating was initiated by JMP Securities with “Market Outperform” on Wednesday, October 7. See Neovasc Inc (US) (NASDAQ:NVCN) latest ratings:
Among 2 analysts covering Platinum Group Metals (NYSEMKT:PLG), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Platinum Group Metals had 2 analyst reports since May 27, 2016 according to SRatingsIntel. The rating was upgraded by IBC to “Sector Perform” on Monday, June 27. The rating was initiated by BMO Capital Markets with “Outperform” on Friday, May 27.
Analysts await Platinum Group Metals Limited (USA) (NYSEMKT:PLG) to report earnings on April, 11.
It closed at $1.53 lastly. It is down 150.82% since August 29, 2016 and is uptrending. It has outperformed by 142.57% the S&P500.
Neovasc Inc. is a specialty medical device company. The company has market cap of $120.41 million. The Firm develops, makes and markets products for the cardiovascular marketplace. It currently has negative earnings. The Company’s segment is the development, manufacture and marketing of medical devices.
